Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
The American Journal of Medicine
|
March 1, 1997
Antiphospholipid antibodies and essential thrombocythemia
C N Harrison, S J Machin
Current Hematologic Malignancy Reports
|
October 14, 2024
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
K Thaw, C N Harrison, P Sriskandarajah
Leukemia & Lymphoma
|
March 26, 2002
Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a review
D P Steensma, C N Harrison, A Tefferi
Lancet (London, England)
|
April 3, 1998
Desirability and problems of early diagnosis of essential thrombocythaemia
C N Harrison, D C Linch, S J Machin
Leukemia
|
November 21, 1998
Quantification of X-chromosome inactivation patterns using RT-PCR of the polymorphic iduronate-2-sulphatase gene and correlation of the results obtained with DNA-based techniques
C N Harrison, R E Gale, D C Linch
Expert Opinion on Drug Safety
|
May 18, 2016
Safety considerations when treating myelofibrosis
J M O'Sullivan, D P McLornan, C N Harrison
European Journal of Haematology
|
August 26, 1998
Outcome of secondary myeloid malignancy in Hodgkin's disease: the BNLI experience
C N Harrison, G Vaughan, S Devereux, et al.
British Journal of Haematology
|
October 23, 1997
Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age
R E Gale, A K Fielding, C N Harrison, et al.
Blood
|
January 13, 1999
A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications
C N Harrison, R E Gale, S J Machin, et al.
Leukemia
|
November 30, 2016
Equivalence of BCSH and WHO diagnostic criteria for ET
C N Harrison, M F McMullin, A R Green, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
The American Journal of Medicine
|
March 1, 1997
Antiphospholipid antibodies and essential thrombocythemia
C N Harrison, S J Machin
Current Hematologic Malignancy Reports
|
October 14, 2024
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
K Thaw, C N Harrison, P Sriskandarajah
Leukemia & Lymphoma
|
March 26, 2002
Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a review
D P Steensma, C N Harrison, A Tefferi
Lancet (London, England)
|
April 3, 1998
Desirability and problems of early diagnosis of essential thrombocythaemia
C N Harrison, D C Linch, S J Machin
Leukemia
|
November 21, 1998
Quantification of X-chromosome inactivation patterns using RT-PCR of the polymorphic iduronate-2-sulphatase gene and correlation of the results obtained with DNA-based techniques
C N Harrison, R E Gale, D C Linch
Expert Opinion on Drug Safety
|
May 18, 2016
Safety considerations when treating myelofibrosis
J M O'Sullivan, D P McLornan, C N Harrison
European Journal of Haematology
|
August 26, 1998
Outcome of secondary myeloid malignancy in Hodgkin's disease: the BNLI experience
C N Harrison, G Vaughan, S Devereux, et al.
British Journal of Haematology
|
October 23, 1997
Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age
R E Gale, A K Fielding, C N Harrison, et al.
Blood
|
January 13, 1999
A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications
C N Harrison, R E Gale, S J Machin, et al.
Leukemia
|
November 30, 2016
Equivalence of BCSH and WHO diagnostic criteria for ET
C N Harrison, M F McMullin, A R Green, et al.
Page
of 3